Chinese Pharmaceuticals have been sold off considerably in recent months, but look very attractive on a valuation basis. There are fundamental problems, but in light of China’s objective of universal health care coverage there is significant upside. See “Healthy Tigers” update in “Inside The Stock Market”.
Aug
04
2011
Asia Thematic Investing: Update On Healthy Tigers Index
Login
For full access, please enter your credentials.
Not a Subscriber?
If you are interested in subscribing to The Leuthold Group, contact us online or give us a call at 612-332-1567.
Contact UsAbout The Author
current issue
featured articles
recent tags
Bank Lending
(1)
Wealth Effect
(9)
Resession
(1)
Dollar
(55)
Inflation
(584)
Time Cycles
(6)
Oil
(48)
Breakeven Rate
(1)
Value
(130)
Treasuries
(79)
Long T-Bonds
(24)
Active vs. Passive
(17)
Yield Curve
(85)
Economy
(282)
Federal Spending
(2)
Stock Market Performance
(1)
Federal Debt/Deficit
(194)
Fed Policy
(173)
Federal Outlays
(1)
Stimulus
(4)